Budget effects of consumption of proton pump inhibitors in Turkey in years 2006-2011

Basit Öğe Kaydı
dc.authorid0000-0001-9916-3800
dc.contributor.authorBilgener, Emrah
dc.date.accessioned2019-05-13T08:58:37Z
dc.date.available2019-05-13T08:58:37Z
dc.date.issued2018
dc.departmentHitit Üniversitesi, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümü
dc.description.abstractObjective: Proton Pump Inhibitors are safe and powerful drugs which used in PU, GERD, gastiritis and other digestive system acid secretion diseases. In this study, comparative analysis of PPI drugs and consumption of products by years in Turkey examined to make a pre-paharmacoecomic analysis. Material and Method: A analysis of by using the results of the comparative analysis published in recent years about PPI drugs and the consumption data of PPI drug, which were taken from Intercontinental Marketing Services - Health (IMSHealth) within years 2006-2011. Result and Discussion: All sales of PPI drugs were increased highly in years 2006-2011 except omeprazole. The consumption of products shows that omeprazole, which had low cost than other drugs not preferred by physicians. In comparative analyzes it was determined that there was no statistically significant difference in efficiency of PPIs. There is a prescription migration to more expensive medicines for the consumption of PPIs, which have no significant difference in treatment. More cost-effective drugs need to be consumed for reimbursement budgets. For this reason, omeprazole consumption should be encouraged in necessary indications, or it is necessary to repay the cost of the other group of drugs from omeprazole's cost. © 2018 Tasarım / Design Kayhan Bolelli.
dc.identifier.citationBilgener, E. (2018). Budget effects of consumption of proton pump inhibitors in Turkey in years 2006-2011. Ankara Universitesi Eczacilik Fakultesi Dergisi, 42(2), 23-31.
dc.identifier.doi10.1501/Eczfak-0000000604
dc.identifier.endpage31en_US
dc.identifier.issn1015-3918
dc.identifier.issue2en_US
dc.identifier.scopusqualityQ3
dc.identifier.startpage23en_US
dc.identifier.urihttps://doi.org/10.1501/Eczfak-0000000604
dc.identifier.urihttps://hdl.handle.net/11491/1171
dc.identifier.volume42en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isotr
dc.publisherUniversity of Ankara
dc.relation.ispartofAnkara Universitesi Eczacilik Fakultesi Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBudgeten_US
dc.subjectCosten_US
dc.subjectPharmacoeconomicsen_US
dc.subjectProton Pump Inhibitorsen_US
dc.titleBudget effects of consumption of proton pump inhibitors in Turkey in years 2006-2011
dc.title.alternativeTürkiye'de 2006-2011 yıllarında proton pompası inhibitörleri tüketiminin bütçeye etkisien_US
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu